相关实验视频

Updated: Jan 7, 2026

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

Published on: September 8, 2015

在良性前列腺增生和代谢综合征中,雄激素受体辅激剂和结构基因的分子概况和临床关联

Feres Camargo Maluf¹, Karina Serafim da Silva¹, Giovana Vilas Boas Caetano¹

¹Laboratório de Investigação Médica 55 (LIM55), Faculdade de Medicina, Hospital das Clínicas HCFMUSP, Universidade de São Paulo, São Paulo 01246-903, SP, Brazil.

|December 30, 2025

概括

良性前列腺增生 (BPH) 涉及雄激素受体联合激活剂和原基因. 升高的PCAF,p300,SRC-1和COL1A1将BPH与代谢综合征联系起来,这表明了新的治疗点.

科学领域:

泌尿器科泌尿器科泌尿器科泌尿器科
分子生物学分子生物学
内分泌学在内分泌学.

背景情况:

良性前列腺增生 (BPH) 是老年男性中普遍存在的疾病.
乙PH有助于下泌尿道症状,前列腺扩大和代谢综合征 (MetS).
雄激素受体 (AR) 信号传导和细胞外基质 (ECM) 重建是BPH病原发生的关键.

研究的目的:

调查AR协激活剂和BPH中的ECM基因的临床相关性.
确定BPH进展的潜在分子生物标志物和治疗点.

主要方法:

从76名BPH患者和5名对照患者的前列腺组织进行定量PCR分析.
评估了AR联合激活剂 (SRC-1,SRC-2,SRC-3,PCAF,p300) 和ECM基因 (COL1A1,COL3A1) 的表达.

主要成果:

在BPH组织中,AR联合激活剂和原基因显著过度表达 (折叠变化≥7.8).
增加的PCAF,p300,SRC-1和COL1A1与更高的PSA水平和前列腺体积相关.
代谢因子 (甘油三,VLDL,HDL) 和MetS成分与特定的基因表达有关.

结论:

在BPH中的一个分子签名将雄激素,代谢和肌肉病理联系起来.
SRC-1,PCAF,p300和COL1A1是BPH的潜在生物标志物和治疗点.
这些发现为BPH分子机制和进展提供了新的见解.

关键词:

类固醇的同调器是安卓的.原蛋白是一种原蛋白.代谢综合征代谢综合征前列腺前列腺前列腺前列腺增生症前列腺增生症

更多相关视频

Laser-capture Microdissection of Human Prostatic Epithelium for RNA Analysis

Laser-capture Microdissection of Human Prostatic Epithelium for RNA Analysis

Published on: November 26, 2015

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

相关概念视频

Co-activators and Co-repressors

Co-activators and Co-repressors

Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...

mTOR Signaling and Cancer Progression

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...